Home Infusion Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Product Type (Infusion Pumps {Elastomeric, Electromechanical, Gravity, Others}, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-Infective, Endocrinology {Diabetes, Others}, Hydration Therapy {Athletes, Others}, Chemotherapy, Enteral Nutrition, Parenteral
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationHome Infusion Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Product Type (Infusion Pumps {Elastomeric, Electromechanical, Gravity, Others}, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-Infective, Endocrinology {Diabetes, Others}, Hydration Therapy {Athletes, Others}, Chemotherapy, Enteral Nutrition, Parenteral
| Forecast Period | 2025-2029 |
| Market Size (2023) | USD 34.77 Billion |
| CAGR (2024-2029) | 8.64% |
| Fastest Growing Segment | Infusion Pumps |
| Largest Market | North America |
Market Overview
Home Infusion Therapy Market was valued at USD 34.77 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.64% through 2029. The Home Infusion Therapy Market encompasses services and products that allow patients to receive intravenous treatments in the comfort of their own homes. This market includes medical equipment, medication pumps, infusion supplies, and medications themselves, in addition to the professional healthcare services required to administer these therapies. The demand for this market is driven by the benefits of home-based care, including patient comfort, reduced hospital stays, and cost savings for both healthcare providers and patients.
Key Market Drivers
Increasing Aging Population Drives the Market Growth
By 2022, there were 771 million people over the age of 65 worldwide, nearly 10% of the world's population. This segment is growing rapidly and is expected to reach 16% in 2050 and eventually this segment is expected to reach 24% by 2100.
Shift Towards Patients-Centric Care Propels the Market Growth
The shift toward patients-centric care plays an important role in driving the growth of Global Home Infusion Therapy Market. According to the Health Care Management Research Consortium (HARC) at the University of Colorado Denver, the second annual Health System Climate Survey outlines health care leaders' goals and plans for 2022. Its finding is the outcome of a survey of 133 US CEOs representing $263 billion in healthcare system revenues, 1.2 million employees. Patient-centric care aims to enhance patient outcomes by providing comprehensive, coordinated, and continuous care. Home infusion therapy supports this objective by ensuring that patients receive uninterrupted and timely treatments. By avoiding hospital-acquired infections and reducing the risk of medical errors associated with inpatient care, home infusion therapy can improve patient safety and outcomes. This positive impact on patient health further drives the demand for home infusion therapy. Patient-centric care highlights the effective participation of patients in their healthcare decision-making processes. Home infusion therapy encourages patient engagement and empowerment by enabling patients to effectively participate in their treatment plans. Patients receiving home infusion therapy have greater control over their healthcare, as they can self-administer medications or receive support from caregivers. This involvement fosters a sense of empowerment and autonomy among patients, leading to improved treatment adherence and overall patient satisfaction this led to the growth of Global Home Infusion Therapy Market.
Increasing Prevalence of Chronic Disease drive the Market Growth
Approximately 422 million people worldwide have diabetes, most of them living in low- and middle-income countries, and 1.5 million people die each year directly from diabetes. Both the number of cases and prevalence of diabetes have increased steadily in recent decades.
Development of Portable & User-Friendly Infusion Pumps
The development of portable and user-friendly infusion pumps is significantly increasing the demand for home infusion therapy globally. Home infusion therapy allows patients to receive intravenous medications, fluids, or nutrition in the comfort of their own homes, rather than in a hospital or clinical setting. Portable infusion pumps offer patients greater flexibility and independence, enabling them to continue with their daily activities while undergoing treatment. Additionally, user-friendly features such as touch-screen interfaces, wireless connectivity, and automated functions make home infusion therapy more accessible and manageable for patients and caregivers alike. As a result, the demand for home infusion therapy is on the rise, driven by factors such as the growing preference for home-based healthcare, advancements in medical technology, and the desire for improved patient outcomes and quality of life. The development of portable and user-friendly infusion pumps is playing a crucial role in meeting this demand, enabling more patients to benefit from the convenience and effectiveness of home infusion therapy globally.
Key Market Challenges
Regulatory Hurdles
Regulatory hurdles are acting as a significant barrier, decreasing the demand for home infusion therapy globally. While home infusion therapy offers numerous benefits, including increased patient convenience, reduced healthcare costs, and improved quality of life, navigating regulatory frameworks can be complex and challenging for patients, caregivers, and healthcare providers. Regulatory requirements vary from country to country and may include licensure, accreditation, certification, and reimbursement criteria that must be met to provide home infusion therapy services.
Additionally, regulatory agencies may impose stringent safety and quality standards to ensure patient safety and mitigate risks associated with home-based treatments. Compliance with these regulations often requires significant investments in infrastructure, training, documentation, and ongoing monitoring, which can deter healthcare providers from offering home infusion therapy services. Moreover, delays or uncertainties in regulatory approvals and reimbursement processes may hinder patient access to home infusion therapy and limit the availability of these services in certain regions. Consequently, regulatory hurdles are impeding the widespread adoption and demand for home infusion therapy globally, highlighting the need for streamlined regulatory pathways and comprehensive support mechanisms to facilitate access to these valuable healthcare services.
Reimbursement Constraints
Reimbursement constraints are a significant factor contributing to the decrease in demand for home infusion therapy globally. While home infusion therapy offers numerous benefits, including convenience, reduced healthcare costs, and improved patient outcomes, reimbursement policies and constraints can pose barriers to access. Healthcare systems and insurance providers may have complex reimbursement structures, coverage limitations, and administrative requirements for home infusion therapy services.
These constraints may include limitations on eligible diagnoses, coverage of specific medications or therapies, and restrictions on reimbursement rates or reimbursement for ancillary services such as nursing visits or equipment rental. Additionally, navigating the reimbursement process can be challenging for patients, caregivers, and healthcare providers, leading to delays or denials of coverage for home infusion therapy. As a result, patients may face financial burdens or opt for alternative treatment options, reducing the demand for home infusion therapy globally. Addressing reimbursement constraints through advocacy, policy reforms, and collaborative efforts among stakeholders is essential to ensure equitable access to home infusion therapy and meet the growing demand for patient-centered healthcare services worldwide.
Key Market Trends
Flexibility of Therapy Scheduling
The flexibility of therapy scheduling is playing a pivotal role in increasing the demand for home infusion therapy globally. Unlike traditional hospital-based treatments, home infusion therapy offers patients the freedom to schedule their treatments according to their own preferences and lifestyle, without the constraints of hospital schedules or commuting to medical facilities. This flexibility allows patients to maintain their daily routines, work commitments, and family responsibilities while receiving necessary medical care in the comfort of their own homes.
Additionally, for individuals living in remote or rural areas, home infusion therapy eliminates the need for long-distance travel to access healthcare services, thereby improving access to treatment and reducing the burden of transportation costs and logistical challenges. As healthcare systems worldwide seek to enhance patient-centered care and improve healthcare outcomes, the flexibility of therapy scheduling offered by home infusion therapy is driving a surge in demand for this convenient and patient-friendly treatment option globally.
Growing Number of Clinical Trials Assessing Home Infusion Therapies
The growing number of clinical trials assessing home infusion therapies is significantly increasing the demand for home infusion therapy globally. Clinical trials play a crucial role in evaluating the safety, efficacy, and feasibility of home-based treatments, including infusion therapies, in diverse patient populations and medical conditions.
As more clinical trials demonstrate the effectiveness and benefits of home infusion therapy compared to traditional hospital-based treatments, there is a corresponding increase in demand from patients and healthcare providers seeking access to these innovative treatment options. Moreover, clinical trial findings provide valuable evidence supporting the expansion of reimbursement coverage and regulatory approval for home infusion therapies, further driving their adoption and utilization. Additionally, the dissemination of positive trial results through scientific publications and medical conferences raises awareness among patients, caregivers, and healthcare professionals, fostering greater acceptance and demand for home infusion therapy as a viable and effective healthcare delivery model globally. Consequently, the growing number of clinical trials assessing home infusion therapies is fueling a surge in demand for these patient-centered treatments worldwide.
Segmental Insights
Product Type
Based on the product type, within the vast and rapidly growing Global Home Infusion Therapy Market, Infusion Pumps stand tall as the undoubted champions. These remarkable devices take center stage due to their pivotal role in ensuring the delivery of precise dosages of medication over consistent time intervals. This capability is of utmost importance for a wide range of treatments that are administered in the comfort of one's home. By facilitating the management of chronic diseases, Infusion Pumps empower patients to take control of their health and well-being outside the confines of a hospital setting. Moreover, the invaluable dosage accuracy provided by these pumps plays a vital role in safeguarding the overall well-being and recovery of patients, elevating their quality of life to new heights. With their unwavering reliability and exceptional functionality, Infusion Pumps have become the bedrock of modern home healthcare, revolutionizing the way patients receive treatment and improving outcomes across the globe.
Application Insights
Based on the application segment, within the Global Home Infusion Therapy Market, Anti-Infective therapy is currently dominating. This sector has witnessed significant growth due to the rising prevalence of chronic infections and the increasing adoption of home healthcare services. The convenience and cost-effectiveness of home infusion therapy have been key factors driving this trend, as patients find it more convenient to receive treatment at home rather than in a hospital setting. Additionally, the personalized care and flexible scheduling offered by home infusion therapy contribute to its popularity among patients. As a result, the demand for Anti-Infective therapy within the home infusion therapy market continues to rise, demonstrating its effectiveness in treating chronic infections and improving patient outcomes.
Regional Insights
In North America, the Global Home Infusion Therapy Market is experiencing dominance due to a multitude of factors. The region boasts advanced healthcare infrastructure, providing state-of-the-art facilities and resources for home infusion therapy. Additionally, significant healthcare expenditure ensures accessibility and affordability of these services to a wider population. Moreover, the steadily growing aging population in North America contributes to the market's growth. With age, individuals become more susceptible to chronic diseases, necessitating long-term care and treatment. Home infusion therapy offers a convenient and effective solution for managing these conditions, allowing patients to receive necessary medications and therapies in the comfort of their own homes.
Recent Developments
- In June 2023, BD (Becton,Dickinson and Company), the world's foremost medical technology company,emerges as the global frontrunner in groundbreaking automated instruments thatprepare clinical diagnostic samples using flow cytometry and a comprehensive"walk-away" workflow solution. The commercial release of thisinnovative solution signifies a significant advancement in standardization andreproducibility in cytodiagnosis.
- In May 2023, BaxterInternational, Inc., a prominent global leader in medical technology, extendsits Biopharmaceutical Solutions ("BPS") business to AdventInternational ("Advent"), a highly reputable and experienced globalprivate company. The announcement confirms the definitive agreement for equityacquisition by Warburg Pincus, one of the world's preeminent growth investors.
- In December 2022, a leading pharmacy providercatering to long-term care and post-acute care facilities proudly announcesVaishali Chokshi, pharmacy operations manager at PharmScript, as the esteemedrecipient of the Aging Media Future Leader Award.
Key Market Players
- CareFusion Corporation
- BriovaRx/Diplomat (UnitedHealth Optum)
- PharMerica Corporation
- Fresenius Kabi
- ICU Medical, Inc.
- B. Braun Melsungen AG
- Baxter International Inc.
- Caesarea Medical Electronics
- Option Care Health
- Smiths Medical, Inc.
- Terumo Corporation
| By Product Type | By Application | By Region |
| |
|
|
|
| |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy